US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ホーム
投資
株式
イギリス
LSE
hVIVO Plc (HVO)
hVIVO Plc (HVO) ニュース

hVIVO Plc (HVO)

7.15

0.05

(0.70%)

終了 7月5日 12:30AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

Cavendish - Morning Note – 16 June 2026

Cavendish - hVIVO - Capital Markets Day review

Last week’s CMD was a clear reminder, in our view, of how hVIVO’s platform breadth has positioned the business for resilient growth into expanding...

Cavendish - Morning Note – 11 June 2026

Cavendish - hVIVO - Capital Markets Day

hVIVO will host a Capital Markets Day today, highlighting its evolution from a human challenge trial (HCT) specialist to an integrated...

hVIVO PLC Holding(s) in Company

hVIVO PLC 09 June 2026 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B9275X97 Issuer Name hVIVO plc UK or...

Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London

Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London PR Newswire CAMBRIDGE, Mass...

hVIVO PLC Consultancy contract with Decoy Therapeutics

hVIVO PLC 01 June 2026 hVIVO plc ("hVIVO", the "Company" or the "Group") Consultancy contract signed with Decoy Therapeutics to support...

Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic

Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic PR Newswire...

hVIVO PLC Grant of awards under Long Term Incentive Plan

hVIVO PLC 29 May 2026 hVIVO plc ("hVIVO, the "Company" or the "Group") Grant of awards under Long Term Incentive Plan London, UK - 29...

hVIVO PLC Capital Markets Day

hVIVO PLC 20 May 2026 hVIVO plc ("hVIVO", the "Company" or the "Group") hVIVO to showcase integrated, full service early clinical...

hVIVO PLC Result of AGM

hVIVO PLC 13 May 2026 hVIVO plc ("hVIVO", the "Company" or the "Group") Result of AGM London, UK - 13 May 2026, hVIVO plc (AIM: HVO), a...

hVIVO PLC Holding(s) in Company

hVIVO PLC 12 May 2026 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B9275X97 Issuer Name HVIVO PLC UK or...

Cavendish - Morning Note – 7 May 2026

hVIVO (HVO) secures £6 million influenza challenge trial contract

hVIVO plc (LSE:HVO) has been awarded a £6 million contract by a clinical-stage biopharmaceutical company to conduct an influenza human challenge...

Cavendish - Morning Note – 7 May 2026

gfp927z

gfp927z 3分前

US Stablecoin consortium -

A huge development last week for the coming US national Stablecoin system. 140 of the biggest players in finance are forming a consortium to run and own the new US digital dollar / stablecoin system they call 'Open US' (links below). The stablecoin is lik

gfp927z

gfp927z 6分前

Bigworld, It looks like a huge development last week for the coming US national Stablecoin system. 140 of the biggest players in finance are forming a consortium to run and own the new US digital dollar / stablecoin system they call 'Open US' (links below). The stablecoin is like a CBDC (digital

Twiggs333

Twiggs333 27分前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 27分前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 27分前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 28分前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

OMOLIVES

OMOLIVES 32分前

Happy Fourth of July to all!...and a big thank you to the French. Vive la France!:

https://x.com/Phoenix2A_1980s/status/2073453266428387385

4u2nv2

4u2nv2 33分前

Every filing from the time Paul and Ben took over said there were 3 preferred shareholders. The third one was never named. Now, it's interesting to question how Newby got controlling interest when we do not know all of the facts concerning what Ben really wanted to accomplish with taking on the comm

Eli's Gone

Eli's Gone 45分前

I'm in: 11-5-24-19

Eli's Gone

Eli's Gone 46分前

gfp927z

gfp927z 46分前

>>> Look At Who Joined Open USD To Understand Where Money Is Going

Forbes

by Zennon Kapron

Jul 02, 2026

https://www.forbes.com/sites/digital-assets/2026/07/02/look-at-who-joined-open-usd-to-understand-where-money-is-going/

Sammy boy

Sammy boy 52分前

Said it 4 months ago Bessent is the problem ! There is a reason he cold-cocked Tommy Boy.

misterfishman

misterfishman 1時間前

Me too my side hobbies are researching new forms of energy from the enviroment,been at this for more than 20 yrs now and have accumilated a great deal oh knowledge.

Atlanta1

Atlanta1 1時間前

Joey - Why do you waste time on this lunatic?

FeMike

FeMike 1時間前

The original randomised primary endpoint (PFS) was negative and showed harm,

The simple fact that you don’t understand pseudo progression is more than enough to establish as also fact that you have no idea what you’re talking about.

1jas

1jas 1時間前

If you go to otcmarkets for AFFU news dated August 22 2023 it does mention AFFU and Dell partnership.

nyt

3 yrs down 79%. 5 yrs down 57%. 10 yrs down over 80%

gemstone57

gemstone57 1時間前

Happy Fourth of July guys we live in the greatest Nation on earth.

Tadaaa

Tadaaa 2時間前

johnydollar

johnydollar 2時間前

Have you ever wondered why clown fish like to hang out around the sea anemones........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆

GoodGuyBill

GoodGuyBill 2時間前

rcbindustry

rcbindustry 2時間前

I'm staying on the sidelines for now. Rocket Companies has potential over the long term, but I think the stock will continue to depend heavily on interest rates and the housing market. I'll be watching the next few quarters before becoming more optimistic.

Genz2

Genz2 2時間前

Now who would have thought of what Steven K Sprague came up with on X recently??? This country, Microsoft, Intel and Wave need Steven’s thinking!!!! If Steven’s court case is still in abeyance that is a real travesty!!! Steven is VERY UNIQUE in how he can masterfully come up with solutions that a

johnydollar

johnydollar 2時間前

You mean naked short enrichment right...........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 Ƕ

Roman516

Roman516 2時間前

Happy 4th of July to all, GoodGuyBill, yes, I agree with you and your comment that "$35 billion is far too low for a treatment that will treat all tumor-based cancers (and we are not even discussing DIRECT, the combo patent, etc)."

If in fact, DCVax-D is able to address the majority o

4.250% Notes due 18/12/2...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。